Advertisement
Screener

CVRx, Inc. (CVRX) Price / Book

2.8 / 5 stars · 68/120 Roast Me

CVRx, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • CVRx, Inc. price/book ratio for the quarter ending 2026-06-30 was 6.82, a 157.11% increase year-over-year.
  • CVRx, Inc. price/book ratio for the quarter ending 2026-03-31 was 8.56, a 86.38% increase year-over-year.
  • CVRx, Inc. price/book ratio for the quarter ending 2025-12-31 was 4.76, a 5.35% increase year-over-year.
  • CVRx, Inc. price/book ratio for the quarter ending 2025-09-30 was 4.41, a 34.80% increase year-over-year.
  • CVRx, Inc. price/book ratio for fiscal 2026 was 6.82.
  • CVRx, Inc. price/book ratio for fiscal 2025 was 4.76, a 5.35% increase from fiscal 2024.
  • CVRx, Inc. price/book ratio for fiscal 2024 was 4.52, a 47.76% decline from fiscal 2023.
  • CVRx, Inc. price/book ratio for fiscal 2023 was 8.64, a 148.88% increase from fiscal 2022.
Available history
2021-06-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-306.82$136.14M$19.95M
2026-03-318.56$249.22M$29.11M
2025-12-314.76$187.08M$39.32M
2025-09-304.41$211.91M$48.05M
2025-06-302.65$153.74M$57.93M
2025-03-314.59$318.62M$69.36M
2024-12-314.52$320.86M$71.06M
2024-09-303.27$213.23M$65.18M
2024-06-304.71$260.33M$55.25M
2024-03-315.93$393.21M$66.26M
2023-12-318.64$656.44M$75.95M
2023-09-303.81$315.74M$82.83M
2023-06-303.56$320.39M$89.96M
2023-03-311.94$193.01M$99.64M
2022-12-313.47$379.18M$109.18M
2022-09-301.62$192M$118.24M
2022-06-300.97$123.66M$127.15M
2022-03-310.9$122.72M$136.8M
2021-12-311.71$249.48M$145.96M
2021-09-302.16$336.62M$155.76M
2021-06-30-0.03$10.26M-$318.93M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-306.82$136.14M$19.95M
2025-12-314.76$187.08M$39.32M
2024-12-314.52$320.86M$71.06M
2023-12-318.64$656.44M$75.95M
2022-12-313.47$379.18M$109.18M
2021-12-311.71$249.48M$145.96M

Similar stocks

Stock NameCountryMarket CapPE Ratio
DarioHealth Corp. (DRIO)$0.066B-1.39
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02